 | It’s an exciting time in the drug discovery and development industry. Every day, we are advancing new hope for many diseases. Yet the journey of a drug isn’t easy. Internal research and development efforts are more costly than ever. And the slow pace of drug discovery, from target identification to drug candidate, is also a challenge forcing companies to rethink processes—all without compromising drug safety.
- Kinases & Phosphatases
- G Protein-Coupled Receptors (GPCRs)
- Ion Channels
- High Content Analysis (HCA)
- BioPharma Services
Click the PDF above for the full document. |